导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 22.69% | 178/1050 |
| 近一周 | -2.28% | 557/1104 |
| 近一月 | -3.51% | 469/1102 |
| 近一季 | 1.75% | 230/1092 |
| 近半年 | 12.23% | 228/1070 |
| 近一年 | 29.08% | 167/1018 |
| 近两年 | 130.42% | 121/926 |
| 近三年 | 84.87% | 116/833 |
| 成立以来 | 175.53% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.23% 468/1070 |
38.86% 266/1101 |
- - |
- - |
| 2025 | 48.59% 204/1065 |
-0.61% 837/1014 |
12.22% 61/1038 |
31.00% 343/1050 |
1.69% 332/1065 |
| 2024 | 4.28% 451/1011 |
-2.80% 466/960 |
-5.50% 659/983 |
8.77% 735/991 |
4.37% 156/1011 |
| 2023 | -7.59% 269/952 |
6.16% 246/880 |
6.13% 31/895 |
-14.14% 752/915 |
-4.48% 450/952 |
| 2022 | -22.22% 416/867 |
-20.35% 532/773 |
7.08% 400/806 |
-6.49% 98/845 |
-2.48% 559/867 |
| 2021 | 36.49% 42/740 |
-2.03% 226/580 |
21.71% 134/659 |
5.53% 118/704 |
8.47% 112/740 |
| 2020 | 76.99% 106/554 |
4.56% 80/419 |
37.56% 43/466 |
10.27% 249/517 |
11.60% 306/554 |
| 2019 | 60.46% 78/410 |
38.43% 81/1146 |
-6.43% 810/1228 |
7.11% 158/390 |
15.65% 43/410 |
| 2018 | -37.19% 273/349 |
- - |
-12.66% 628/990 |
-15.81% 953/1000 |
-16.36% 932/1080 |
| 2017 | 2.68% 167/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 国联竞争优势 VS. 东吴新产业精选股票A(580008) |